$9.48
-0.05[-0.52%]
At close: Apr 19
$9.48
0[0.00%]
PreMarket: 4:06PM EDT
Astellas Pharma
(OTCPK:ALPMY)Latest News for Astellas Pharma Stock (OTC:ALPMY)
Astellas Pharma Stock (OTC: ALPMY)
Categories: All
Monday, March 04, 2024
Wednesday, January 31, 2024
Friday, December 29, 2023
Thursday, December 28, 2023
Monday, December 18, 2023
Saturday, December 16, 2023
Monday, December 11, 2023
Thursday, October 05, 2023
Friday, September 22, 2023
Wednesday, September 20, 2023
Wednesday, July 12, 2023
Friday, July 07, 2023
Thursday, July 06, 2023
Thursday, June 08, 2023
Monday, May 15, 2023
- Google Launches Tools To Detect Fake Images, Apple May Encounter Delays In iPhone 15 Production, Shake Shack Sees Activist Investor Proxy Fight: Today's Top StoriesVandana Singh - May 15, 2023, 9:47AM
- Astellas' Menopause Drug Sores FDA Approval, After Regulatory SetbackVandana Singh - May 15, 2023, 6:57AM
Monday, May 01, 2023
- Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%Vandana Singh - May 1, 2023, 2:32PM
- Stocks Rise As Investors Welcome JPMorgan's Purchase Of First Republic's Assets; Treasury Yields Rise As Banking Crisis RecedesShanthi Rexaline - May 1, 2023, 2:16PM
- First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top StoriesVandana Singh - May 1, 2023, 9:58AM
- Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'Vandana Singh - May 1, 2023, 8:00AM